WallStreetZenWallStreetZen

NASDAQ: VRDN
Viridian Therapeutics Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Viridian Therapeutics revenue was $305.00k for the trailing 12 months ending Jun 30, 2025, with N/A growth year over year. Quarterly revenue for the quarter (Q2 2025) ending on Jun 30, 2025 was $75.0k, up 4.2% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, VRDN annual revenue was $302.0k, with -3.8% growth year-over-year.

VRDN past revenue growth

How has VRDN's revenue growth performed historically?

Company
5.9%
Industry
148.77%
Market
20.34%
VRDN's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
VRDN's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
VRDN's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

VRDN revenue history

Current Revenue
$305.0k
Current Earnings
-$344.1M
Current Profit Margin
-112,806.9%

Be the first to know when VRDN announces revenue.

VRDN Revenue History By Year

VRDN Yearly RevenueVRDN RevenueVRDN ChangeVRDN Revenue Growth
2024-12-31$302.00k-$12.00k-3.82%
2023-12-31$314.00k-$1.46M-82.28%
2022-12-31$1.77M-$1.19M-40.20%
2021-12-31$2.96M$1.91M+182.19%
2020-12-31$1.05M-$3.41M-76.46%
2019-12-31$4.46M-$3.93M-46.80%
2018-12-31$8.39M$4.38M+109.49%
2017-12-31$4.00M$526.00k+15.13%
2016-12-31$3.48M$939.00k+37.00%
2015-12-31$2.54M-$1.78M-41.25%
2014-12-31$4.32M$4.00k+0.09%
2013-12-31$4.32M-$90.04k-2.04%
2012-12-31$4.41MN/AN/A

1 of 1

Viridian Therapeutics Revenue FAQ

What was VRDN's revenue last quarter?

On Invalid Date, Viridian Therapeutics (NASDAQ: VRDN) reported Q2 2025 revenue of $75.00 thousand up 4.17% year over year. In the same quarter last year, Viridian Therapeutics's revenue was $72.00 thousand.

What was Viridian Therapeutics's revenue in 2024?

Viridian Therapeutics's annual revenue for the twelve months ending Dec 31, 2024 was $302.00 thousand, a 3.82% decrease year over year.

How much does Viridian Therapeutics make in a day?

Based on Viridian Therapeutics annual revenue for the past five years, VRDN makes an average of $3,507.40 per day.

What was Viridian Therapeutics's annual revenue growth in the past year?

As of Q4 2025, Viridian Therapeutics's revenue has grown 5.9% year over year. This is 142.86 percentage points lower than the US Biotechnology industry revenue growth rate of 148.77%. Viridian Therapeutics's revenue in the past year totaled $305.00 thousand.

How much does Viridian Therapeutics make in a year?

Viridian Therapeutics's revenue by year for the past five years is:
  • Viridian Therapeutics's revenue for the twelve months ending Dec 31, 2024 was $302.00 thousand, a 3.82% decrease year over year.
  • Viridian Therapeutics's annual revenue for Dec 31, 2023 was $314.00 thousand, a 82.28% decrease from 2022.
  • Viridian Therapeutics's annual revenue for 2022 was $1.77 million, a 40.2% decrease from 2021.
  • Viridian Therapeutics's annual revenue for 2021 was $2.96 million, a 182.19% increase from 2020.
  • Viridian Therapeutics's annual revenue for 2020 was $1.05 million, a 76.46% decrease from 2019.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.